E6910

Pioglitazone hydrochloride

≥98% (HPLC), powder, hepatic gluconeogenesis blocker

• Szinonimák: 5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione monohydrochloride
• Tapasztalati képlet (Hill-képlet): C₁₉H₂₀N₂O₃S · HCl
• CAS-szám: 112529-15-4
• Molekulatömeg: 392.90
• MDL-szám: MFCD04975446
• UNSPSC kód: 41106305
• PubChem Substance ID: 329799001
• NACRES: NA.77

Tulajdonságok

• product name: Pioglitazone hydrochloride, ≥98% (HPLC)
• Minőségi szint: 100
• Teszt: ≥98% (HPLC)
• form: powder
• szín: white to off-white
• oldhatóság: DMSO: ≥10 mg/mL
• kezdeményező: Takeda
• tárolási hőmérséklet: room temp
• SMILES string: Cl.CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1
• InChI: 1S/C19H20N2O3S.ClH/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17;/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23);1H
• Nemzetközi kémiai azonosító kulcs: GHUUBYQTCDQWRA-UHFFFAOYSA-N
• Géninformáció: human ... PPARG(5468)

Leírás

Általános leírás

Pioglitazone hydrochloride consists of poly-morphs, form I and form II. It is an oral antidiabetic agent, that is a member of the thiazolidinedione group.

Alkalmazás

Pioglitazone hydrochloride has been used:

• to administer to mice model and treated the hepatoma cell line to study its effect on regulating insulin-degrading enzyme (IDE) in diet-induced obese (DIO) C57BL/6 mice
• in drug preparation to analyze its effects on shortening and calcium transport in ventricular myocytes from the Goto-Kakizaki (GK) type 2 diabetic rat
• to treat HepG2 cells with peroxisome proliferator-activated receptor γ (PPARγ) agonists to examine its effect on TOMM40-, APOE- and APOC1-mRNA levels

Biokémiai/fiziológiai hatások

Pioglitazone hydrochloride is a PPARγ agonist and thiazolidinedione (TZD) anti-diabetic. Pioglitazone is a selective agonist of the nuclear receptor peroxisome proliferator-activated receptor γ (PPAR-γ) and to a lesser extent PPAR-α.

Pioglitazone hydrochloride is usually used to treat type-II diabetes. It has the ability to block hepatic gluconeogenesis.

Tulajdonságok és előnyök

This compound is a featured product for ADME Tox research. Click here to discover more featured ADME Tox products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

This compound is featured on the AMPKs and Nuclear Receptors (PPARs) pages of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by Takeda. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Biztonsági adatok

• Piktogramok: GHS08,GHS07
• Figyelmeztetés: Warning
• Figyelmeztető mondatok: H302,H351
• Óvintézkedésre vonatkozó mondatok: P202 - P264 - P280 - P301 + P312 - P308 + P313 - P405
• Veszélyességi osztályok: Acute Tox. 4 Oral - Carc. 2
• Tárolási osztály kódja: 11 - Combustible Solids
• WGK: WGK 3
• Lobbanási pont (F): Not applicable
• Lobbanási pont (C): Not applicable